Skip to content

Does giving calcium during cesarean section help reduce blood loss? A study on High Risk Mothers

Effect of prophylactic intravenous calcium gluconate administration on blood loss in women undergoing cesarean section with risk factor for postpartum hemorrhage - a randomized controlled trial - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087002
Enrollment
180
Registered
2025-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Administration of Calcium gluconate: Giving 1 gram (10ml) calcium gluconate intravenously over 10 minutes for high risk pregnant women Control Intervention1: Normal saline: 10 ml of iso

Sponsors

JIPMER Intramural Research fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 years and more ASA 2 and 3 Gestational age more than 34 weeks Planned for c-section under spinal anesthesia Pregnant females with high risk for blood loss during c-section like previous cesarean section, twin pregnancy, severe obesity, history of previous postpartum hemorrhage

Exclusion criteria

Exclusion criteria: Pregnant females with heart disease, chronic renal disease, placenta accreta sprectum, pregnant females who are taking calcium channel blockers like nifedipine tablets

Design outcomes

Primary

MeasureTime frame
To compare the effect of intravenous calcium gluconate with placebo on reduction of intrapartum blood loss in pregnant women posted for cesarean section with risk factor of postpartum hemorrhage.Timepoint: At the end of the surgery

Secondary

MeasureTime frame
1.verbal numerical rating scale of uterine tone 2.baseline & postoperative hemoglobin 3.baseline & post operative ionized calcium 4.total intraoperative intravenous fluids administered, total dose of vasopressors used & second line utero-tonic usedTimepoint: 1.Baseline, at 5 minutes, 10 minutes, 15 minutes after giving study drug 2. Baseline, at postoperative day 1 3.Baseline, at postoperative day 1 4.At the end of surgery

Countries

India

Contacts

Public ContactDr Aswini kuberan

Jawaharlal Institute of Postgraduate Medical Education And Reserch

ashdoctor.kuberan@gmail.com9914017949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026